Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


14 March -15 March 2018

Translating the Human Microbiome into Commercially Viable Medicines

Industry Insights. Regulatory Feedback. Innovative Solutions

Call for Speakers

The deadline for abstract submission is Friday 29th September. Please submit your ideas for consideration now - Speak up and share your ideas

Speak at Microbiome Therapeutics Europe 2018

Share your know-how, insight or innovation. We are now accepting Speaker Submissions – Please submit your ideas for consideration.We are actively looking for innovative presentations across these areas:

  • R&D and Emerging Technologies for Microbiome Drug Development (e.g. omics)
  • Understanding Mechanisms of Action
  • Translational and Models for Drug Development (e.g. animal models)
  • Lessons Learnt from Microbiome Therapeutics in Clinical Development 
  • Regulatory Pathways for Microbiome Therapeutics 
  • Overcoming Manufacturing and Formulation Challenges 
  • Commercialisation of Microbiome Therapeutics